{ "model": { "rank": 5523, "code": "thing-q798309", "model_id": "vr.tr.bcg-vaccine", "name": "BCG vaccine", "purpose": "Enable an agent to recognise BCG vaccine, assess the identity and usability of a particular presentation or lot, and identify the evidence and authorisation needed for its handling and vaccination use.", "family": "Thing Registry", "category": "Physical world and living systems", "status": "research-draft", "kind": "thing", "plane": "PHY", "domain": "PHY.OBJ", "industry": "", "version": "", "url": "/models/thing/q798309/", "tier": 2, "score": 66, "payload": { "layer": "wikidata", "aliases": [], "aliasCount": 0, "merged": 0, "knownIn": 66, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q798309", "url": "https://www.wikidata.org/wiki/Q798309", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-09T22:32:57Z", "providers": [ "Codex" ], "breadth": "recalled by Codex without web access - no source was read", "missingProviders": [], "pass": 2, "cost": { "grok": { "seconds": 19.6, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a0884c-7c4c-7992-8a64-f1f5c5459302\n--------\nuser\nDescribe what is already known about one registered thing. Answer as JSON only, no prose around it.\n\nThing: BCG vaccine\nSense to describe: (none recorded)\nDomain code: PHY.OBJ\nAlso known as: (none)\n\n\nContext for this batch of 1001 things:\n# Batch 005: 1001 reg", "usd": 0, "recall": true }, "codex": { "seconds": 68.7, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a0884c-7c47-71b0-9f0a-69ff24fc9913\n--------\nuser\nYou are drafting a Vercy meta-model for one registered thing. Answer as JSON only, no prose around it.\n\nThing: BCG vaccine\nRegistry id: vr.tr.bcg-vaccine\nPlane / domain: PHY / PHY.OBJ\nRegistry definition: (none recorded)\nNames folded into this entry: (none)\n\n\n" } } }, "metaModel": { "id": "THING-Q798309", "registryId": "vr.tr.bcg-vaccine", "name": "BCG vaccine", "version": "0.1.0-research.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "PHY.OBJ" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q798309/", "model": { "registry_id": "vr.tr.bcg-vaccine", "name": "BCG vaccine", "purpose": "Enable an agent to recognise BCG vaccine, assess the identity and usability of a particular presentation or lot, and identify the evidence and authorisation needed for its handling and vaccination use.", "definition": "BCG vaccine is a live attenuated bacterial vaccine derived from Mycobacterium bovis, used to prevent tuberculosis, with its most established protection being against tuberculous meningitis and disseminated tuberculosis in young children.", "scope_statement": "This model owns BCG vaccine as a class of live attenuated Mycobacterium bovis preparations intended for vaccination against tuberculosis, including the product, lot and presentation attributes needed to judge a physical supply; it does not prescribe care for an individual.", "in_scope": [ "BCG vaccine identity, biological lineage and distinction between the vaccine class, licensed products and physical lots", "Product-specific formulation, presentation, diluent and preparation requirements", "Viable potency, batch release evidence and quality status", "Storage, transport, reconstitution and remaining usable life", "Vaccination purpose, product-authorised administration constraints and links to applicable guidance", "Traceability, recall status and disposition of unused or compromised material" ], "out_of_scope": [ "Tuberculosis disease, diagnosis and treatment", "Individual vaccination eligibility, prescribing and clinical management", "Intravesical BCG products and bladder-cancer treatment protocols", "Mycobacterium bovis as an organism independent of its vaccine preparation", "Population immunisation programmes and their policy decisions", "Syringes, cold-chain equipment and other supporting devices as independently modelled things" ], "distinguishing_features": [ "The preparation is identified as live attenuated BCG derived from Mycobacterium bovis, rather than an unrelated tuberculosis vaccine candidate.", "The labelled intended use is vaccination; a BCG preparation labelled for intravesical treatment requires a neighbouring therapeutic-product model.", "The preparation contains viable vaccine organisms, distinguishing it from purified protein derivative used in tuberculin testing.", "A named BCG strain or manufacturer identifies a variant or product within this vaccine class, rather than a separate registry thing.", "A lot number, container and expiry identify physical vaccine supply, rather than the abstract vaccine class or a record of its administration." ], "characteristics": [ { "name": "BCG strain or substrain", "kind": "category", "unit_or_values": "Product-declared strain or substrain designation; unverified; unknown", "why_it_matters": "Connects the preparation to its biological lineage and prevents unsupported assumptions that all BCG products are interchangeable." }, { "name": "Product and manufacturer identity", "kind": "relation", "unit_or_values": "Links to the named product, manufacturer and applicable authorisation record", "why_it_matters": "Determines which formulation, preparation instructions and release specifications apply." }, { "name": "Labelled intended use", "kind": "category", "unit_or_values": "Tuberculosis vaccination; another declared use requiring boundary review; unknown", "why_it_matters": "Separates vaccination presentations from other preparations bearing the BCG name." }, { "name": "Physical presentation", "kind": "category", "unit_or_values": "Product-declared dosage form, container type and single-dose or multidose presentation", "why_it_matters": "Controls preparation requirements, dose accounting and handling after opening." }, { "name": "Viable potency", "kind": "measurement", "unit_or_values": "Product-specified viable-count unit per labelled dose or volume, with assay method and acceptance range", "why_it_matters": "Records biological potency without treating mass, nominal organism count and viable count as equivalent." }, { "name": "Required diluent", "kind": "relation", "unit_or_values": "Link to the product-designated diluent and required reconstitution volume in mL", "why_it_matters": "Supports verification that a proposed diluent and volume match the specific vaccine presentation." }, { "name": "Labelled dose and route", "kind": "category", "unit_or_values": "Product- and recipient-category-specific labelled volume in mL and administration route", "why_it_matters": "Prevents instructions from one product or recipient category being applied indiscriminately to another." }, { "name": "Storage and exposure requirements", "kind": "category", "unit_or_values": "Product-specific temperature limits in °C, light protection and other labelled handling conditions", "why_it_matters": "Provides the criteria against which documented storage and transport exposure can be assessed." }, { "name": "Preparation state", "kind": "state", "unit_or_values": "Unopened; opened; reconstituted; partly used; discarded; unknown", "why_it_matters": "Changes the applicable handling instructions and usable-life clock." }, { "name": "Usable-life limits", "kind": "measurement", "unit_or_values": "Labelled expiry date and applicable time after opening or reconstitution in minutes or hours", "why_it_matters": "Supports calculation of a discard deadline using the correct product instructions." }, { "name": "Quality and disposition status", "kind": "state", "unit_or_values": "Released; awaiting verification; quarantined; recalled; expired; rejected; discarded", "why_it_matters": "Distinguishes physical possession of vaccine from evidence that the supply is available for authorised use." }, { "name": "Lot provenance", "kind": "relation", "unit_or_values": "Links to manufacturer lot, supplier, release evidence and custody records", "why_it_matters": "Enables authenticity checks, recall matching and investigation of suspected defects." } ], "affordances": [ "Identify a preparation as BCG vaccine and associate it with the correct product, strain and lot records.", "Compare vaccine and diluent identifiers against product-specific preparation instructions and flag unresolved mismatches.", "Assess documented storage exposure and usable-life limits, referring uncertain excursions for qualified disposition.", "Retrieve applicable vaccination guidance and surface product restrictions for an authorised clinician to assess.", "Trace affected supply during a recall and record quarantine, return or disposal under the responsible procedure." ] }, "sources": [], "structure": { "bundles": [ { "id": "bcg-identity-and-boundaries", "name": "BCG identity and boundaries", "description": "Establishes which biological preparation and intended-use sense the registry entry covers.", "rationale": "The BCG name spans vaccine lineages, commercial presentations and therapeutic uses that must not be conflated.", "layers": [ { "id": "biological-identity", "name": "Biological identity", "description": "Connects the vaccine preparation to its declared BCG lineage.", "findings": [ { "id": "strain-lineage-evidence", "name": "Strain lineage evidence", "description": "Record the declared BCG strain or substrain and the evidence connecting it to the named vaccine product.", "questions": [ { "text": "How does the product documentation identify its BCG strain or substrain?", "kind": "definition", "id": "strain-lineage-evidence-q01" }, { "text": "Which manufacturer or regulatory document establishes that lineage for this presentation?", "kind": "provenance", "id": "strain-lineage-evidence-q02" } ] } ] }, { "id": "intended-use-and-instance-boundaries", "name": "Intended use and instance boundaries", "description": "Separates vaccine identity from related BCG therapies, diagnostic reagents and physical instances.", "findings": [ { "id": "vaccination-product-classification", "name": "Vaccination product classification", "description": "Use intended-use evidence to place a preparation within the vaccine class and retain product and lot distinctions beneath it.", "questions": [ { "text": "Does the label identify this preparation for vaccination, intravesical treatment or another use?", "kind": "boundary", "id": "vaccination-product-classification-q01" }, { "text": "Does the record describe the vaccine class, a named product, a lot or an individual container?", "kind": "boundary", "id": "vaccination-product-classification-q02" } ] } ] } ] }, { "id": "viable-preparation-and-quality", "name": "Viable preparation and quality", "description": "Captures the formulation and quality evidence relevant to a vaccine containing live organisms.", "rationale": "BCG usability depends on a defined biological preparation and satisfactory quality evidence, which appearance alone cannot establish.", "layers": [ { "id": "formulation-and-presentation", "name": "Formulation and presentation", "description": "Identifies the supplied dosage form, container and declared constituents.", "findings": [ { "id": "declared-vaccine-composition", "name": "Declared vaccine composition", "description": "Record product-specific composition and presentation without generalising one manufacturer's formulation to all BCG vaccines.", "questions": [ { "text": "What dosage form, excipients and container presentation does the applicable product document declare?", "kind": "definition", "id": "declared-vaccine-composition-q01" }, { "text": "Which components are supplied with this presentation, and which must be sourced separately under its instructions?", "kind": "boundary", "id": "declared-vaccine-composition-q02" } ] } ] }, { "id": "potency-and-release", "name": "Potency and release", "description": "Relates viable potency and required quality controls to a specific product and lot.", "findings": [ { "id": "lot-quality-evidence", "name": "Lot quality evidence", "description": "Associate the lot with applicable viable-potency specifications and release evidence, keeping unavailable results explicit.", "questions": [ { "text": "What viable-potency range, reporting unit and assay basis apply to this product?", "kind": "measurement", "id": "lot-quality-evidence-q01" }, { "text": "What evidence establishes that this lot satisfied the required quality controls and was released?", "kind": "provenance", "id": "lot-quality-evidence-q02" } ] } ] } ] }, { "id": "preservation-and-reconstitution", "name": "Preservation and reconstitution", "description": "Tracks how storage exposure and preparation change the usability of BCG vaccine supply.", "rationale": "A live vaccine's labelled expiry is insufficient to judge usability after compromised storage or reconstitution.", "layers": [ { "id": "storage-exposure", "name": "Storage exposure", "description": "Compares custody and exposure history with product-specific preservation requirements.", "findings": [ { "id": "preservation-evidence", "name": "Preservation evidence", "description": "Record applicable storage conditions, observed exposures and unresolved gaps requiring disposition.", "questions": [ { "text": "What temperature, light and other exposure limits apply before and after preparation?", "kind": "measurement", "id": "preservation-evidence-q01" }, { "text": "Do custody records show an excursion or missing interval, and who may decide its effect on usability?", "kind": "action", "id": "preservation-evidence-q02" } ] } ] }, { "id": "diluent-and-use-clock", "name": "Diluent and use clock", "description": "Controls the transition from supplied presentation to prepared vaccine.", "findings": [ { "id": "reconstitution-compatibility-and-deadline", "name": "Reconstitution compatibility and deadline", "description": "Link the required diluent and preparation event to the applicable storage conditions and discard deadline.", "questions": [ { "text": "Which diluent identity and volume are explicitly designated for this vaccine presentation?", "kind": "definition", "id": "reconstitution-compatibility-and-deadline-q01" }, { "text": "What preparation timestamp and product-specific rule determine the latest permissible use time?", "kind": "measurement", "id": "reconstitution-compatibility-and-deadline-q02" }, { "text": "What disposition is required if the diluent, preparation time or preparation conditions cannot be verified?", "kind": "action", "id": "reconstitution-compatibility-and-deadline-q03" } ] } ] } ] }, { "id": "vaccination-purpose-and-use-constraints", "name": "Vaccination purpose and use constraints", "description": "Connects the physical vaccine to its intended protective role and authoritative constraints on use.", "rationale": "An agent must distinguish identifying usable stock from deciding whether and how a particular person should receive it.", "layers": [ { "id": "protective-role-and-evidence", "name": "Protective role and evidence", "description": "Frames protection claims by tuberculosis outcome, population and evidence context.", "findings": [ { "id": "bounded-protection-claims", "name": "Bounded protection claims", "description": "Attach any protection claim to its specific outcome and population rather than representing BCG as uniformly preventing all tuberculosis.", "questions": [ { "text": "Which tuberculosis outcomes and recipient populations does each cited protection claim address?", "kind": "boundary", "id": "bounded-protection-claims-q01" }, { "text": "Which authoritative evidence supports the claim, and what limitations does it report?", "kind": "provenance", "id": "bounded-protection-claims-q02" } ] } ] }, { "id": "authorised-administration-interface", "name": "Authorised administration interface", "description": "Exposes product instructions and clinical-policy dependencies without making individual treatment decisions.", "findings": [ { "id": "product-and-recipient-use-constraints", "name": "Product and recipient use constraints", "description": "Link the presentation to labelled dose, route, recipient categories and restrictions requiring clinical review.", "questions": [ { "text": "What labelled route and dose volume apply to this product and the relevant recipient category?", "kind": "measurement", "id": "product-and-recipient-use-constraints-q01" }, { "text": "Which contraindications, precautions and prior-vaccination or testing requirements must the authorised clinician assess under applicable guidance?", "kind": "action", "id": "product-and-recipient-use-constraints-q02" }, { "text": "Which decisions belong to the recipient's clinical record rather than to the vaccine object?", "kind": "boundary", "id": "product-and-recipient-use-constraints-q03" } ] } ] } ] }, { "id": "traceability-and-disposition", "name": "Traceability and disposition", "description": "Maintains the evidence needed to locate, restrict and dispose of BCG vaccine supply.", "rationale": "Lot-specific defects, recalls and live biological remnants require traceable decisions throughout the supply lifecycle.", "layers": [ { "id": "supply-and-recall-traceability", "name": "Supply and recall traceability", "description": "Connects physical containers to product, lot, supplier and current release or recall status.", "findings": [ { "id": "lot-status-verification", "name": "Lot status verification", "description": "Retain identifiers and authoritative status evidence sufficient to recognise affected stock and prevent unsupported release.", "questions": [ { "text": "Which container identifiers connect this supply to its manufacturer lot and supplier records?", "kind": "provenance", "id": "lot-status-verification-q01" }, { "text": "Which current notice or responsible authority determines whether this lot is released, restricted or recalled?", "kind": "provenance", "id": "lot-status-verification-q02" } ] } ] }, { "id": "unusable-material-handling", "name": "Unusable material handling", "description": "Handles vaccine rendered unusable by expiry, preparation limits, damage or unresolved quality concerns.", "findings": [ { "id": "quarantine-and-biological-disposal", "name": "Quarantine and biological disposal", "description": "Record why live BCG material leaves usable stock and link its final disposition to the applicable biological-waste procedure.", "questions": [ { "text": "What event requires this container to be quarantined, returned or discarded?", "kind": "action", "id": "quarantine-and-biological-disposal-q01" }, { "text": "Which approved procedure governs residual live BCG vaccine, contaminated containers and spill material at this location?", "kind": "action", "id": "quarantine-and-biological-disposal-q02" } ] } ] } ] }, { "id": "evidence-and-external-alignment", "name": "Evidence and external alignment", "description": "What the world already says about this thing, gathered so the model can be checked against it.", "rationale": "A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.", "layers": [ { "id": "reported-evidence", "name": "Reported evidence", "description": "Findings from the breadth pass, kept separate from the structural claims.", "findings": [ { "id": "evidence-confidence-notes", "name": "Check these first", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "This describes the vaccine category, not a particular manufacturer's product or an individual dose.", "Administration volume, viable bacterial content, storage and post-reconstitution limits require verification against the specific product label.", "Strain availability and national vaccination policies require current verification; the statements here are recalled knowledge, not source-checked research." ], "questions": [ { "id": "evidence-confidence-notes-q01", "text": "Which of these check these first hold for the sense of BCG vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-kinds", "name": "Kinds and varieties", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "BCG Danish strain vaccines", "BCG Tokyo strain vaccines", "BCG Russian strain vaccines", "BCG Moreau strain vaccines" ], "questions": [ { "id": "evidence-kinds-q01", "text": "Which of these kinds and varieties hold for the sense of BCG vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-identifiers", "name": "Identifiers and schemes", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "scheme": "WHO Anatomical Therapeutic Chemical classification", "value_or_pattern": "J07AN01", "note": "Identifies BCG tuberculosis vaccines; BCG preparations for cancer immunotherapy have a separate classification." } ], "questions": [ { "id": "evidence-identifiers-q01", "text": "Which of these identifiers and schemes hold for the sense of BCG vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-standards-and-regulation", "name": "Standards and regulation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "WHO recommendations for the quality, safety and efficacy of BCG vaccines govern internationally recognized manufacturing and quality-control expectations.", "National medicines regulators authorize specific products and their approved labeling.", "National immunization authorities determine eligibility, timing and contraindications within vaccination programmes." ], "questions": [ { "id": "evidence-standards-and-regulation-q01", "text": "Which of these standards and regulation hold for the sense of BCG vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-real-world-use", "name": "Real-world use", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Routine infant tuberculosis vaccination in countries with substantial tuberculosis transmission.", "Selective vaccination of children at increased tuberculosis exposure risk in some low-incidence countries." ], "questions": [ { "id": "evidence-real-world-use-q01", "text": "Which of these real-world use hold for the sense of BCG vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-measurements", "name": "Typical measurements", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "quantity": "Common intradermal administration volume", "typical_range": "0.05 or 0.1, depending on age and product", "unit": "mL" }, { "quantity": "Common refrigerated storage temperature", "typical_range": "2-8", "unit": "°C" } ], "questions": [ { "id": "evidence-measurements-q01", "text": "Which of these typical measurements hold for the sense of BCG vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-failure-modes-and-hazards", "name": "Failure modes and hazards", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Protection against pulmonary tuberculosis is variable, and vaccination does not reliably prevent infection.", "Local abscesses and suppurative lymphadenitis can occur; administration technique affects local complication risk.", "Rare disseminated BCG infection can occur, particularly in people with severe immune deficiencies.", "Heat, light exposure or improper handling after reconstitution can reduce vaccine viability and potency.", "Vaccination can affect tuberculin skin-test interpretation; a positive result cannot automatically be attributed to BCG." ], "questions": [ { "id": "evidence-failure-modes-and-hazards-q01", "text": "Which of these failure modes and hazards hold for the sense of BCG vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-regional-variation", "name": "Regional variation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Many higher-incidence countries use routine neonatal vaccination, whereas some lower-incidence countries use selective vaccination or do not routinely administer BCG.", "Available vaccine strains, manufacturers and presentations differ between countries.", "Age eligibility and policies concerning repeat vaccination differ between national programmes." ], "questions": [ { "id": "evidence-regional-variation-q01", "text": "Which of these regional variation hold for the sense of BCG vaccine this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-neighbours", "name": "Neighbouring kinds and how to tell them apart", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "name": "Mycobacterium bovis", "difference": "The bacterial species from which BCG was attenuated; naturally occurring M. bovis can cause tuberculosis." }, { "name": "Intravesical BCG", "difference": "A BCG preparation administered into the bladder for cancer immunotherapy; its indication, route and dosing distinguish it from tuberculosis vaccination." }, { "name": "Tuberculin purified protein derivative", "difference": "A non-live diagnostic reagent used in skin testing, rather than a vaccine." }, { "name": "Tuberculosis", "difference": "The infectious disease targeted by vaccination, rather than the preventive biological product." } ], "questions": [ { "id": "evidence-neighbours-q01", "text": "Which of these neighbouring kinds and how to tell them apart hold for the sense of BCG vaccine this model covers, and on what evidence?", "kind": "provenance" } ] } ] } ] } ] }, "openQuestions": [ "Does the existing world-model catalogue already cover BCG vaccine or an equivalent concept that this registry entry should link to?", "Which authoritative product records establish the strain, formulation, viable-potency specifications and permitted substitutions for the presentations to be represented?", "What exact storage, diluent, reconstitution and discard requirements apply to each included presentation, and how are uncertain excursions resolved?", "Which current jurisdiction-specific labels and vaccination policies govern dose, route, recipient restrictions and any differences between them?", "What evidence supports outcome- and population-specific protection claims, and which proposed non-tuberculosis effects should remain outside the established vaccination purpose?" ], "statistics": { "bundles": 6, "layers": 11, "findings": 19, "questions": 31 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "unclassified", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a BCG vaccine, record what state it is in, and decide what may be done with it.", "whatItIs": "Enable an agent to recognise BCG vaccine, assess the identity and usability of a particular presentation or lot, and identify the evidence and authorisation needed for its handling and vaccination use.", "characteristics": { "substance": "material", "origin": "manufactured", "agency": "inert", "mobility": "varies" }, "whatYouCanDoWithIt": [ "observed and measured" ], "distinguishingFeatures": [ "Described in 66 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a BCG vaccine, and on what evidence are they told apart?" ], "whatItIsMadeOf": "matter you can touch", "physicalCharacter": [ "Mobility varies between examples.", "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state" ], "howItIsRecognised": [ "Recognised by form and material. The registry holds no appearance data, so what a BCG vaccine looks like has to come from research." ], "relatedModels": [], "standing": "Described in 66 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one BCG vaccine from another, and a BCG vaccine from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a BCG vaccine sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a BCG vaccine from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "form-and-composition", "name": "Form, composition and condition", "description": "What a BCG vaccine is made of, what shape and size it takes, and what state it is in.", "rationale": "A physical thing can be measured, and a model that cannot record its measurements cannot support any decision that depends on them.", "layers": [ { "id": "form-and-dimensions", "name": "Form and dimensions", "description": "Shape, size, mass and the ranges these take across examples.", "findings": [ { "id": "measurable-dimensions", "name": "Measurable dimensions and their units", "description": "The quantities worth recording and the units they are recorded in.", "questions": [ { "id": "measurable-dimensions-q01", "text": "What identifies and describes the dimensions of a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "measurable-dimensions-q02", "text": "Who or what asserted this about the dimensions of a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "measurable-dimensions-q03", "text": "What may an agent decide or do once the dimensions of a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "material-and-composition", "name": "Material and composition", "description": "Materials, parts and how they are put together.", "findings": [ { "id": "parts-and-materials", "name": "Parts and materials", "description": "What a BCG vaccine is built from and which parts are replaceable.", "questions": [ { "id": "parts-and-materials-q01", "text": "What identifies and describes the composition of a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "parts-and-materials-q02", "text": "Who or what asserted this about the composition of a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "parts-and-materials-q03", "text": "What may an agent decide or do once the composition of a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "condition-and-integrity", "name": "Condition and integrity", "description": "Wear, damage, health and the difference between working and broken.", "findings": [ { "id": "condition-assessment", "name": "Condition, damage and health", "description": "How the condition of a BCG vaccine is judged and by whom.", "questions": [ { "id": "condition-assessment-q01", "text": "What identifies and describes the condition of a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "condition-assessment-q02", "text": "Who or what asserted this about the condition of a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "condition-assessment-q03", "text": "What may an agent decide or do once the condition of a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "place-and-movement", "name": "Place and movement", "description": "Where a BCG vaccine is, how it got there and where it may go (varies).", "rationale": "A thing that can move needs its position recorded with a time, or every later claim about it is about a place it has left.", "layers": [ { "id": "location-and-placement", "name": "Location and placement", "description": "Position, containment and the reference frame the position is given in.", "findings": [ { "id": "position-and-frame", "name": "Position, container and reference frame", "description": "Where a BCG vaccine is, and what that position is measured against.", "questions": [ { "id": "position-and-frame-q01", "text": "What identifies and describes the location of a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "position-and-frame-q02", "text": "Who or what asserted this about the location of a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "position-and-frame-q03", "text": "What may an agent decide or do once the location of a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "movement-and-transfer", "name": "Movement and transfer", "description": "How a BCG vaccine is carried, installed or relocated.", "findings": [ { "id": "movement-events", "name": "Movement events and constraints", "description": "What counts as a movement, what records it and what limits it.", "questions": [ { "id": "movement-events-q01", "text": "What identifies and describes the movement of a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "movement-events-q02", "text": "Who or what asserted this about the movement of a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "movement-events-q03", "text": "What may an agent decide or do once the movement of a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a BCG vaccine passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a BCG vaccine between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a BCG vaccine, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a BCG vaccine is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "use-and-operation", "name": "Use and operation", "description": "What can be done with a BCG vaccine and what it takes to do it.", "rationale": "An agent that can recognise a thing but not act on it has only half a model.", "layers": [ { "id": "intended-use", "name": "Intended use and function", "description": "What a BCG vaccine is for, and what it is used for anyway.", "findings": [ { "id": "function-and-purpose", "name": "Function, purpose and misuse", "description": "The function a BCG vaccine performs and the uses that fall outside it.", "questions": [ { "id": "function-and-purpose-q01", "text": "What identifies and describes the use of a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "function-and-purpose-q02", "text": "Who or what asserted this about the use of a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "function-and-purpose-q03", "text": "What may an agent decide or do once the use of a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "handling-and-procedure", "name": "Handling and procedure", "description": "The steps, skills and tools involved in using a BCG vaccine.", "findings": [ { "id": "procedures-and-skills", "name": "Procedures, skills and required tools", "description": "What an agent needs before it can act on a BCG vaccine at all.", "questions": [ { "id": "procedures-and-skills-q01", "text": "What identifies and describes handling a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "procedures-and-skills-q02", "text": "Who or what asserted this about handling a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "procedures-and-skills-q03", "text": "What may an agent decide or do once handling a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a BCG vaccine came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a BCG vaccine and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a BCG vaccine is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a BCG vaccine, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a BCG vaccine, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a BCG vaccine is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 6, "layers": 13, "findings": 15, "questions": 45 } } } }